GLP-1s Like Ozempic, Wegovy Can Help Maintain Lower Calorie Intake for Over 1 Year

Recent research has found that GLP-1s, like Ozempic and Wegovy, can help you maintain a lower calorie intake for more than a year. Image Credit: Jon Challicom/Getty A new study found that people taking semaglutide (Ozempic and Wegovy) maintained a significantly lower calorie intake after 60 weeks on the medication. Participants taking semaglutide consistently consumed 24% to 30% fewer calories than those receiving a placebo throughout the study. The findings suggest semaglutide may continue supporting weight loss even after differences in hunger and food cravings begin to fade. People taking semaglutide for weight loss maintained a significantly lower calorie intake after 60 weeks on the medication, according to a new study. The findings, published July 16 in the American Journal of Clinical Nutrition , give more insight into how GLP-1 medications such as Wegovy and Ozempic (both brand names for semaglutide) can support both initial weight loss and long-term weight maintenance. How semaglutide’s effects on calorie intake were studied The 60-week trial enrolled 120 adults with overweight or obesity. Participants received either a once-weekly 2.4-milligram dose of semaglutide …